Maternal use of antihypertensive drugs in early pregnancy and delivery outcome, notably the presence of congenital heart defects in the infants
- First Online:
- 523 Downloads
To investigate the association between maternal use of antihypertensives in early pregnancy and delivery outcome, notably infant congenital malformations.
A cohort study of 1,418 women who had used antihypertensive drugs in early pregnancy but had no diabetes diagnosis were identified from the Swedish Medical Birth Register.
There was an excess risk for placental abruption, caesarean section, delivery induction, and post-delivery hemorrhage in women taking hypertensives. Infants were more often than expected born preterm, were small for gestational age, and had an excess of various neonatal symptoms. Cardiovascular defects occurred with an adjusted odds ratio of 2.59 (95% CI 1.92–3.51). The results were similar when the woman had used ACE inhibitors or other antihypertensives, notably beta blockers. Stillbirth rate was increased (risk ratio 1.87, 95% CI 1.02–3.02), again without any clear drug specificity.
There seems to be little drug specificity in the association between maternal use of antihypertensives and an increased risk for infant cardiovascular defects.
KeywordsACE inhibitors Antihypertensives Beta-blocking agents Cardiovascular defects Congenital malformations Stillbirths
- 1.Rey E, Couturier A (1994) The prognosis of pregnancy in women with chronic hypertension. Am J Obst Gynecol 181:410–416Google Scholar
- 2.McCowan LM, Buist RG, North RA et al (1996) Perinatal morbidity in chronic hypertension. Br J Obstet Gynecol 103:123–129Google Scholar
- 3.Sibal BM, Caritis SN, Hauth JC et al (2000) Preterm delivery in women with pregestational diabetes or chronic hypertension relative to women with uncomplicated pregnancies. The National Institute of Child Health and Human Development – Fetal Medicine Units Network. Am J Obst Gynecol 183:1520–1524CrossRefGoogle Scholar
- 5.Abalos E, Duley L, Steyn DW et al (2007) Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database of Systematic Reviews 1: CD002252. doi:10.1002/14651858.CD002252.pub2.
- 6.Heinonen OP, Slone D, Shapiro S (1977) Birth defects and drugs in pregnancy. Publishing Sciences Group, Littleton, MAGoogle Scholar
- 9.National Board of Health and Welfare, Centre for Epidemiology (2003) The Swedish Medical Birth Register – a summary of content and quality. http://www.sos.se/FULLTEXT/112/2003-112-3/2003-112-3.pdf. Accessed May 12, 2008
- 11.National Board of Health and Welfare, Centre for Epidemiology (2004) Registration of congenital malformations in Swedish health registers. http://www.socialstyrelsen.se/Publicerat/2004/5120/2004-112-1.htm. Accessed May 12, 2008
- 12.Källén B, Otterblad Olausson P (2001) Monitoring of maternal drug use and infant congenital malformations. Does loratadine cause hypospadias? Int J Risk Safety Med 14:115–119Google Scholar
- 15.Briggs GG, Freeman RK, Yaffe SJ (2005) Drugs in pregnancy and lactation, 7th edn. Lippincott Williams and Wilkins, PhiladelphiaGoogle Scholar